These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9877207)

  • 1. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner.
    Cerillo G; Rees A; Manchanda N; Reilly C; Brogan I; White A; Needham M
    J Steroid Biochem Mol Biol; 1998 Oct; 67(2):79-88. PubMed ID: 9877207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1.
    Walters MR; Dutertre M; Smith CL
    J Biol Chem; 2002 Jan; 277(3):1669-79. PubMed ID: 11700319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
    Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
    Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1.
    Malayer JR; Cheng J; Woods VM
    Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
    Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
    Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression.
    Chaidarun SS; Alexander JM
    Mol Endocrinol; 1998 Sep; 12(9):1355-66. PubMed ID: 9731704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
    Hall JM; McDonnell DP; Korach KS
    Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
    Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
    Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
    Webb P; Nguyen P; Valentine C; Lopez GN; Kwok GR; McInerney E; Katzenellenbogen BS; Enmark E; Gustafsson JA; Nilsson S; Kushner PJ
    Mol Endocrinol; 1999 Oct; 13(10):1672-85. PubMed ID: 10517669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
    Wolf JS; Chen Z; Dong G; Sunwoo JB; Bancroft CC; Capo DE; Yeh NT; Mukaida N; Van Waes C
    Clin Cancer Res; 2001 Jun; 7(6):1812-20. PubMed ID: 11410524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation.
    Liao MH; Tai YT; Cherng YG; Liu SH; Chang YA; Lin PI; Chen RM
    Br J Nutr; 2014 Jan; 111(1):55-63. PubMed ID: 23829885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.